MAPT and Alzheimer disease: Thus, it is now accepted that extra-cellular accumulation of Aβ fibrils does not induce tau accumulation; consistently, antibody-based pharmacological treatments targeting Aβ in AD mice decreased brain Aβ deposition, leaving unaltered tau accumulation12–15.